319 related articles for article (PubMed ID: 30382873)
1. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
[TBL] [Abstract][Full Text] [Related]
2. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
[TBL] [Abstract][Full Text] [Related]
3. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
4. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis.
Bing ZT; Yang GH; Xiong J; Guo L; Yang L
IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479
[TBL] [Abstract][Full Text] [Related]
5. A 6-Gene Risk Signature Predicts Survival of Glioblastoma Multiforme.
Zhao J; Wang L; Hu G; Wei B
Biomed Res Int; 2019; 2019():1649423. PubMed ID: 31531345
[TBL] [Abstract][Full Text] [Related]
6. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
[TBL] [Abstract][Full Text] [Related]
7. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
PeerJ; 2022; 10():e12768. PubMed ID: 35111402
[TBL] [Abstract][Full Text] [Related]
8. Large-Scale Analysis Reveals Gene Signature for Survival Prediction in Primary Glioblastoma.
Prasad B; Tian Y; Li X
Mol Neurobiol; 2020 Dec; 57(12):5235-5246. PubMed ID: 32875483
[TBL] [Abstract][Full Text] [Related]
9. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract][Full Text] [Related]
10. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
11. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients.
Tang X; Xu P; Wang B; Luo J; Fu R; Huang K; Dai L; Lu J; Cao G; Peng H; Zhang L; Zhang Z; Chen Q
Front Oncol; 2019; 9():812. PubMed ID: 31508371
[No Abstract] [Full Text] [Related]
13. Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis.
Li C; Pu B; Gu L; Zhang M; Shen H; Yuan Y; Liao L
FEBS Open Bio; 2021 Mar; 11(3):833-850. PubMed ID: 33423377
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
15. CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme.
Zhao H; Zhou X; Yuan G; Hou Z; Sun H; Zhai N; Huang B; Li X
Clin Transl Oncol; 2021 Mar; 23(3):565-571. PubMed ID: 32661826
[TBL] [Abstract][Full Text] [Related]
16. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
Mukherjee S
Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
[TBL] [Abstract][Full Text] [Related]
17. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
[TBL] [Abstract][Full Text] [Related]
18. Identification of
Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702
[No Abstract] [Full Text] [Related]
19. Identification of a long noncoding RNA signature to predict outcomes of glioblastoma.
Li D; Lu J; Li H; Qi S; Yu L
Mol Med Rep; 2019 Jun; 19(6):5406-5416. PubMed ID: 31059035
[TBL] [Abstract][Full Text] [Related]
20. A 4-gene panel predicting the survival of patients with glioblastoma.
Guo XX; Su J; He XF
J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
